Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Trans-latanoprost | 913258-34-1 | MFCD03411996 | 98.4% | C26H40O5 | 10MG
SDP

Catalog No. 5000260508
Encompass_Preferred

trans-Latanoprost is the trans isomer of latanoprost (5,6-trans-latanoprost) provided as a research-grade chemical reference for studies of glaucoma and elevated intraocular pressure. It has molecular formula C26H40O5, molecular weight 432.59, and is offered with a reported purity of 98.35% across multiple pack sizes for laboratory use.

  • High reported purity (98.35%).
  • Characterized for analytical and research applications.
  • Applicable to glaucoma and ocular hypertension research.
  • Available in multiple lab-friendly pack sizes.
  • Provided with analytical characterization data for reproducible results.

Catalog No. 50-002-60508 Supplier Medchemexpress LLC Supplier No. HY13516310MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

trans-Latanoprost is the trans isomer of latanoprost (5,6-trans-latanoprost) provided as a research-grade chemical reference for studies of glaucoma and elevated intraocular pressure. It has molecular formula C26H40O5, molecular weight 432.59, and is offered with a reported purity of 98.35% across multiple pack sizes for laboratory use.

  • High reported purity (98.35%).
  • Characterized for analytical and research applications.
  • Applicable to glaucoma and ocular hypertension research.
  • Available in multiple lab-friendly pack sizes.
  • Provided with analytical characterization data for reproducible results.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.